Trial intelligence / Profile preview

Metaraminol pre-infusion for prevention of spinal anesthesia-related hypotension during cesarean section

ChiCTR1900026007Phase 4Not yet recruiting

Sponsor
The Second Xiangya Hospital
Start
Oct 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of metahydroxylamine and ephedrine in maternal hypotension (3 arms), sponsored by The Second Xiangya Hospital. Primary endpoints: Systolic blood pressure, Heart rate and 2 more. Planned start Oct 2019; status: not yet recruiting.

02

Drugs

metahydroxylamineephedrine
03

Conditions

maternal hypotension

Beyond the preview

Go deeper on ChiCTR1900026007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900026007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call